Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Tackling bioactive glass excessive in vitro bioreactivity: Preconditioning approaches for cell culture tests.

Ciraldo FE, Boccardi E, Melli V, Westhauser F, Boccaccini AR.

Acta Biomater. 2018 Jul 15;75:3-10. doi: 10.1016/j.actbio.2018.05.019. Epub 2018 May 21. Review.

2.

Incorporation of bioactive glass nanoparticles in electrospun PCL/chitosan fibers by using benign solvents.

Liverani L, Lacina J, Roether JA, Boccardi E, Killian MS, Schmuki P, Schubert DW, Boccaccini AR.

Bioact Mater. 2017 May 17;3(1):55-63. doi: 10.1016/j.bioactmat.2017.05.003. eCollection 2018 Mar.

3.

Incorporation of Calcium Containing Mesoporous (MCM-41-Type) Particles in Electrospun PCL Fibers by Using Benign Solvents.

Liverani L, Boccardi E, Beltrán AM, Boccaccini AR.

Polymers (Basel). 2017 Oct 4;9(10). pii: E487. doi: 10.3390/polym9100487.

4.

Synthesis of Monodispersed Ag-Doped Bioactive Glass Nanoparticles via Surface Modification.

Kozon D, Zheng K, Boccardi E, Liu Y, Liverani L, Boccaccini AR.

Materials (Basel). 2016 Mar 24;9(4). pii: E225. doi: 10.3390/ma9040225.

5.

Study of the mechanical stability and bioactivity of Bioglass(®) based glass-ceramic scaffolds produced via powder metallurgy-inspired technology.

Boccardi E, Melli V, Catignoli G, Altomare L, Jahromi MT, Cerruti M, Lefebvre LP, De Nardo L.

Biomed Mater. 2016 Feb 2;11(1):015005. doi: 10.1088/1748-6041/11/1/015005.

PMID:
26836444
6.

Uniform Surface Modification of 3D Bioglass(®)-Based Scaffolds with Mesoporous Silica Particles (MCM-41) for Enhancing Drug Delivery Capability.

Boccardi E, Philippart A, Juhasz-Bortuzzo JA, Beltrán AM, Novajra G, Vitale-Brovarone C, Spiecker E, Boccaccini AR.

Front Bioeng Biotechnol. 2015 Nov 6;3:177. doi: 10.3389/fbioe.2015.00177. eCollection 2015.

Supplemental Content

Loading ...
Support Center